| Literature DB >> 35175844 |
Jacqueline T DesJardin1, Joanna Chikwe2, Rebecca T Hahn3, Judy W Hung4, Francesca N Delling1.
Abstract
As populations age worldwide, the burden of valvular heart disease has grown exponentially, and so has the proportion of affected women. Although rheumatic valve disease is declining in high-income countries, degenerative age-related causes are rising. Calcific aortic stenosis and degenerative mitral regurgitation affect a significant proportion of elderly women, particularly those with comorbidities. Women with valvular heart disease have been underrepresented in many of the landmark studies which form the basis for guideline recommendations. As a consequence, surgical referrals in women have often been delayed, with worse postoperative outcomes compared with men. As described in this review, a more recent effort to include women in research studies and clinical trials has increased our knowledge about sex-based differences in epidemiology, pathophysiology, diagnostic criteria, treatment options, outcomes, and prognosis.Entities:
Keywords: aortic valve; clinical trial; epidemiology; heart valve diseases; mitral valve; prognosis; sex characteristics
Mesh:
Year: 2022 PMID: 35175844 PMCID: PMC8869851 DOI: 10.1161/CIRCRESAHA.121.319914
Source DB: PubMed Journal: Circ Res ISSN: 0009-7330 Impact factor: 17.367